Which medical journals publish research on Extra Super Vidalista?

[cliffordfosterr]

Extra Super Vidalista is a brand name for a medication that combines Tadalafil (used for erectile dysfunction) and Dapoxetine (used for premature ejaculation). Research on medications like Extra Super Vidalista might be published in medical journals that focus on urology, sexual health, or pharmacology. Here are a few examples of medical journals that might publish research related to Extra Super Vidalista:

1. The Journal of Sexual Medicine: This journal focuses on all aspects of human sexuality and publishes research on pharmacological treatments for sexual disorders.
2. International Journal of Impotence Research: This journal covers research on erectile dysfunction and related topics, including pharmacological treatments like Tadalafil.
3. Journal of Urology: While more broadly focused on urology, this journal often publishes research related to sexual health and treatments for erectile dysfunction.
4. European Urology: Another leading journal in the field of urology that may include research on medications for erectile dysfunction and premature ejaculation.
5. Journal of Pharmacology and Pharmacotherapeutics: This journal publishes research related to pharmacological treatments and could potentially cover studies on Tadalafil and Dapoxetine.

It's important to note that the specific brand name "Extra Super Vidalista" might not always be mentioned explicitly in research articles, as studies often focus on the generic components (Tadalafil and Dapoxetine). Searching for studies on these individual components may yield relevant research. Additionally, databases like PubMed or Google Scholar can be useful for finding recent publications on this topic.